Compare UFPT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPT | OGN |
|---|---|---|
| Founded | 1963 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 1996 | 2020 |
| Metric | UFPT | OGN |
|---|---|---|
| Price | $190.70 | $6.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $289.00 | $11.75 |
| AVG Volume (30 Days) | 156.9K | ★ 3.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ 15.44 | N/A |
| EPS | ★ 8.75 | 0.72 |
| Revenue | $602,797,000.00 | ★ $6,216,000,000.00 |
| Revenue This Year | $8.12 | $0.42 |
| Revenue Next Year | $5.72 | $1.67 |
| P/E Ratio | $21.95 | ★ $8.83 |
| Revenue Growth | ★ 19.50 | N/A |
| 52 Week Low | $182.87 | $5.69 |
| 52 Week High | $274.93 | $13.25 |
| Indicator | UFPT | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 39.81 |
| Support Level | $185.32 | N/A |
| Resistance Level | $206.13 | $7.87 |
| Average True Range (ATR) | 7.89 | 0.27 |
| MACD | 1.51 | 0.06 |
| Stochastic Oscillator | 30.77 | 41.55 |
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.